deltatrials
Unknown OBSERVATIONAL NCT02415452

Researches of Retinal Artery Lesions and Acute Coronary Syndrome (REACS)

Retinal Artery Lesions to Predict Long-term Outcomes in Patients With Acute Coronary Syndrome After Drug-Eluting Stent Implantation

Sponsor: Beijing Haidian Hospital

Updated 8 times since 2017 Last updated: Jan 16, 2016 Started: Jul 31, 2006 Primary completion: May 31, 2013 Completion: Jan 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02415452, this observational or N/A phase trial focuses on Acute Coronary Syndrome and remains ongoing. Sponsored by Beijing Haidian Hospital, it has been updated 8 times since 2006, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Feb 2018 · 13 months · monthly snapshotActive Not Recruiting~Feb 2018 – ~Apr 2018 · 59 days · monthly snapshotUnknown Status~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotUnknown Status~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

  3. Oct 2021 — Jul 2024 [monthly]

    Unknown Status

  4. Jan 2021 — Oct 2021 [monthly]

    Unknown Status

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status

Show 3 earlier versions
  1. Apr 2018 — Jun 2018 [monthly]

    Unknown Status

    Phase: NANone

  2. Feb 2018 — Apr 2018 [monthly]

    Unknown Status NA

    Status: Active Not RecruitingUnknown Status

  3. Jan 2017 — Feb 2018 [monthly]

    Active Not Recruiting NA

    First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Beijing Haidian Hospital
  • Beijing Mentougou District Hospital
  • Beijing Shijitan Hospital, Capital Medical University
  • Capital Medical University
Data source: Capital Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.